18 Apr 2024
21:41 CEST |
VEOLIA ENVIRONNEMENT |
Veolia Sets Bold Growth Goals in the United States, Boosting Its Ecological Solutions to Improve Economic Growth and Public Health for Americans
|
65102030 Water |
Other subject |
18 Apr 2024
21:41 CEST |
VEOLIA ENVIRONNEMENT |
Veolia fixe des objectifs de croissance ambitieux aux États-Unis en renforçant ses solutions écologiques au service de la croissance économique et de la santé publique des Américains
|
65102030 Water |
Other subject |
18 Apr 2024
20:38 CEST |
AMUNDI |
Mise à disposition du Document d’Enregistrement Universel 2023
|
30202010 Asset Managers and Custodians |
Corporate life |
18 Apr 2024
20:38 CEST |
AMUNDI |
2023 Universal Registration Document available
|
30202010 Asset Managers and Custodians |
Corporate life |
18 Apr 2024
20:02 CEST |
MANITOU BF |
Mise à disposition du Document d’Enregistrement Universel 2023
|
50204020 Machinery: Construction and Handling |
Income |
18 Apr 2024
20:02 CEST |
MANITOU BF |
Availability of the 2023 Universal Registration Document (URD)
|
50204020 Machinery: Construction and Handling |
Income |
18 Apr 2024
19:29 CEST |
ECOSLOPS |
Ecoslops : Résultats annuels 2023
|
60101030 Oil Equipment and Services |
- |
18 Apr 2024
19:29 CEST |
ECOSLOPS |
Ecoslops : 2023 annual results
|
60101030 Oil Equipment and Services |
- |
18 Apr 2024
19:03 CEST |
DANONE |
Danone: Information on the total number of voting rights and shares
|
45102020 Food Products |
Other subject |
18 Apr 2024
19:03 CEST |
DANONE |
DANONE : Informations relatives au nombre total de droits de vote et d’actions
|
45102020 Food Products |
Other subject |
18 Apr 2024
19:00 CEST |
VIEL ET COMPAGNIE |
VIEL & Cie : Réduction de capital par annulation d’actions
|
30202015 Investment Services |
Other financial transaction |
18 Apr 2024
19:00 CEST |
DEKUPLE |
DÉKUPLE: MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2023
|
40301020 Media Agencies |
Income |
18 Apr 2024
18:17 CEST |
SMTPC |
SMTPC_Mise à disposition du Rapport annuel 2023
|
50206060 Transportation Services |
Legal |
18 Apr 2024
18:15 CEST |
GROUPE SFPI |
SFPI GROUP: publication des résultats 2023
|
40301030 Publishing |
General meeting / Board Meeting |
18 Apr 2024
18:15 CEST |
GROUPE SFPI |
SFPI GROUP: publication of 2023 annual results
|
40301030 Publishing |
General meeting / Board Meeting |
18 Apr 2024
18:11 CEST |
PHOTONIKE CAPITAL |
Nucleus Life AG approval of Financial Statements 2023 next April, 29th. Net Profit at 596.897 CHF
|
30202010 Asset Managers and Custodians |
Commercial results |
18 Apr 2024
18:00 CEST |
L'OREAL |
First quarter 2024 sales
|
40204035 Cosmetics |
Sales |
18 Apr 2024
18:00 CEST |
PRODWAYS GROUP |
Activity of the 1st quarter 2024: EUR 16 M in revenue
|
50204050 Machinery: Specialty |
Sales, Income |
18 Apr 2024
18:00 CEST |
KERLINK |
KERLINK : 2023 full-year results. Confident business outlook for 2024.
|
15101010 Telecommunications Equipment |
General meeting / Board Meeting |
18 Apr 2024
18:00 CEST |
ESSILORLUXOTTICA |
EssilorLuxottica: Fatturato del primo trimestre 2024 - Solida traiettoria di crescita del fatturato nel primo trimestre
|
20102015 Medical Supplies |
Commercial results |
18 Apr 2024
18:00 CEST |
OBIZ S.A. |
Le groupe Obiz(C) conclut un protocole d'accord en vue de l'acquisition de HA PLUS PME, plateforme d'achats qui permet aux entreprises de réaliser des économies
|
10101020 Consumer Digital Services |
Legal |
18 Apr 2024
18:00 CEST |
AMPLITUDE SURGICAL |
Amplitude Surgical - Chiffre d’affaires consolidé 9 mois de l’exercice 2023-24 de 79,6 M€, en progression de +6,1% à taux constants
|
20102010 Medical Equipment |
Sales |
18 Apr 2024
18:00 CEST |
ESSILORLUXOTTICA |
EssilorLuxottica: Q1 2024 Revenue - Solid revenue trend in the first quarter
|
20102015 Medical Supplies |
Commercial results |
18 Apr 2024
18:00 CEST |
AELIS FARMA |
Aelis Farma annonce la dernière visite du dernier patient (Last Patient Last Visit ou LPLV) de l’étude de phase 2b avec AEF0117 dans le traitement de l’addiction au cannabis
|
20103010 Biotechnology |
Other subject |
18 Apr 2024
18:00 CEST |
ONCODESIGN PRECISION MEDICINE |
Degroof Petercam Initiates Coverage of Oncodesign Precision Medicine
|
20103010 Biotechnology |
Other subject |
18 Apr 2024
18:00 CEST |
THERANEXUS |
Theranexus and BBDF announce final and positive safety and efficacy data in the Phase I/II trial testing Batten-1
|
20103010 Biotechnology |
Legal |
18 Apr 2024
18:00 CEST |
L'OREAL |
Chiffre d’affaires du 1er trimestre 2024
|
40204035 Cosmetics |
Sales |
18 Apr 2024
18:00 CEST |
KERLINK |
KERLINK : Résultats annuels 2023. Confiance dans les perspectives d’activité 2024.
|
15101010 Telecommunications Equipment |
General meeting / Board Meeting |
18 Apr 2024
18:00 CEST |
NEOLIFE |
Changement de gouvernance à la tête du Conseil de surveillance de NEOLIFE
|
50101035 Building Materials: Other |
- |
18 Apr 2024
18:00 CEST |
PRODWAYS GROUP |
Activité de 1er trimestre 2024 : 16 M EUR de revenus
|
50204050 Machinery: Specialty |
Sales, Income |
18 Apr 2024
18:00 CEST |
ONCODESIGN PRECISION MEDICINE |
Degroof Petercam initie la couverture d’Oncodesign Precision Medicine
|
20103010 Biotechnology |
Other subject |
18 Apr 2024
18:00 CEST |
ESSILORLUXOTTICA |
EssilorLuxottica: Chiffre d'affaires T1 2024 - Trajectoire solide du chiffre d’affaires au premier trimestre
|
20102015 Medical Supplies |
Commercial results |
18 Apr 2024
18:00 CEST |
AELIS FARMA |
Aelis Farma Announces the Last Patient, Last Visit in its Clinical Phase 2b Trial with AEF0117 for the Treatment of Cannabis Use Disorder
|
20103010 Biotechnology |
Other subject |
18 Apr 2024
18:00 CEST |
INTEGRAGEN |
IntegraGen : Résultats annuels 2023 – Excédent brut d’exploitation positif reflétant la bonne maîtrise des coûts
|
20103010 Biotechnology |
Income |
18 Apr 2024
18:00 CEST |
INTEGRAGEN |
IntegraGen: Annual Results 2023 - Positive EBITDA Reflecting Tight Cost Control
|
20103010 Biotechnology |
Income |
18 Apr 2024
18:00 CEST |
AMPLITUDE SURGICAL |
Amplitude Surgical - Consolidated 9-Month Sales for FY 2023-24 of €79.6m, up +6.1% at Constant Exchange Rates
|
20102010 Medical Equipment |
Sales |
18 Apr 2024
18:00 CEST |
THERANEXUS |
Theranexus et BBDF annoncent les données finales et positives de sécurité et d'efficacité de Batten-1 dans l'étude de phase 1/2
|
20103010 Biotechnology |
Legal |
18 Apr 2024
17:52 CEST |
DIAGNOSTIC MEDICAL SYSTEMS |
Résultats annuels 2023 et chiffre d’affaires du 1er trimestre 2024
|
20102010 Medical Equipment |
Commercial results |
18 Apr 2024
17:47 CEST |
PULLUP ENTERTAINMENT |
FOCUS ENTERTAINMENT: PULLUP ENTERTAINMENT ANNONCE UN CHIFFRE D'AFFAIRES AU QUATRIEME TRIMESTRE EN CROISSANCE DE +12% A 59 M€
|
40203040 Electronic Entertainment |
Sales, Other subject |
18 Apr 2024
17:47 CEST |
PULLUP ENTERTAINMENT |
FOCUS ENTERTAINMENT: PULLUP ENTERTAINMENT ANNOUNCES FOURTH-QUARTER REVENUE GROWTH OF +12% TO €59M
|
40203040 Electronic Entertainment |
Sales, Other subject |
18 Apr 2024
17:45 CEST |
IPSOS |
Ipsos: Continued momentum in Q1
|
40301020 Media Agencies |
Income |
18 Apr 2024
17:45 CEST |
IPSOS |
Ipsos : Poursuite de la dynamique de croissance au 1er trimestre
|
40301020 Media Agencies |
Income |
18 Apr 2024
17:45 CEST |
PULLUP ENTERTAINMENT |
FOCUS ENTERTAINMENT: AHMED BOUKHELIFA APPOINTED DEPUTY CHIEF EXECUTIVE OFFICER OF PULLUP ENTERTAINMENT, IN CHARGE OF THE STUDIOS
|
40203040 Electronic Entertainment |
Other subject |
18 Apr 2024
17:45 CEST |
PULLUP ENTERTAINMENT |
FOCUS ENTERTAINMENT: NOMINATION D’AHMED BOUKHELIFA DIRECTEUR GÉNÉRAL DÉLÉGUE CHARGÉ DES STUDIOS
|
40203040 Electronic Entertainment |
Other subject |
18 Apr 2024
17:45 CEST |
ARGAN |
ARGAN: Scrip dividend - Subscribed by 28% of the shareholding in 2024
|
35102030 Office REITs |
Change in Capital |
18 Apr 2024
17:45 CEST |
CLASQUIN |
CLASQUIN : MISE A DISPOSITION DU RAPPORT ANNUEL 2023
|
50206040 Delivery Services |
Legal |
18 Apr 2024
17:45 CEST |
ARGAN |
ARGAN : Paiement du dividende en actions - 28 % de l’actionnariat y souscrit en 2024
|
35102030 Office REITs |
Change in Capital |
18 Apr 2024
17:45 CEST |
DAMARTEX |
DAMARTEX / Chiffre d’affaires des neuf premiers mois de l’exercice 2023/2024
|
40401020 Apparel Retailers |
Share history |
18 Apr 2024
17:45 CEST |
ORAPI |
Correction: ORAPI : Mise à disposition du Rapport Financier Annuel 2023
|
55201000 Chemicals: Diversified |
Other subject |
18 Apr 2024
17:43 CEST |
SPIE |
Press release - SPIE - Closing of the acquisition of ICG Group in Germany
|
50101015 Engineering and Contracting Services |
Mergers, Acquiqitions, Transferts |